| abstract |
The present invention relates to the development of compounds useful as inhibitors of protein kinases, such as the JAK family, ROCK and PKA kinases. The pyrrolopyrimidine compound of the present invention or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable composition thereof are effective as inhibitors of protein kinases such as JAK family, ROCK and PKA kinase. In certain embodiments, these compounds are effective as inhibitors of JAK3 protein kinase. [Selection figure] None |